Sarcoma Metabolomics: Current Horizons and Future Perspectives

被引:10
|
作者
Esperanca-Martins, Miguel [1 ,2 ,3 ]
Fernandes, Isabel [1 ,3 ,4 ]
Soares do Brito, Joaquim [4 ,5 ]
Macedo, Daniela [6 ]
Vasques, Hugo [4 ,7 ]
Serafim, Teresa [2 ]
Costa, Luis [1 ,3 ,4 ]
Dias, Sergio [2 ,4 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Med Oncol Dept, P-1649028 Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Vasc Biol & Canc Microenvironm Lab, P-1649028 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Translat Oncobiol Lab, P-1649028 Lisbon, Portugal
[4] Univ Lisbon, Fac Med, P-1649028 Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Orthoped & Traumatol Dept, P-1649028 Lisbon, Portugal
[6] Hosp Lusiadas Lisboa, Med Oncol Dept, P-1500458 Lisbon, Portugal
[7] Inst Portugues Oncol Francisco Gentil, Gen Surg Dept, P-1099023 Lisbon, Portugal
关键词
sarcoma; soft tissue sarcoma; bone sarcoma; gastrointestinal stromal tumor; metabolomics; metabolism; SOFT-TISSUE SARCOMA; IN-VITRO; CELL-LINES; CANCER; OSTEOSARCOMA; TUMORS; METABOLISM; INHIBITORS; HALLMARKS; PATHWAY;
D O I
10.3390/cells10061432
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The vast array of metabolic adaptations that cancer cells are capable of assuming, not only support their biosynthetic activity, but also fulfill their bioenergetic demands and keep their intracellular reduction-oxidation (redox) balance. Spotlight has recently been placed on the energy metabolism reprogramming strategies employed by cancer cells to proliferate. Knowledge regarding soft tissue and bone sarcomas metabolome is relatively sparse. Further characterization of sarcoma metabolic landscape may pave the way for diagnostic refinement and new therapeutic target identification, with benefit to sarcoma patients. This review covers the state-of-the-art knowledge on cancer metabolomics and explores in detail the most recent evidence on soft tissue and bone sarcoma metabolomics.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Metabolomics in endometriosis: challenges and perspectives for future studies
    Ortiz, Camila N.
    Torres-Reveron, Annelyn
    Appleyard, Caroline B.
    REPRODUCTION AND FERTILITY, 2021, 2 (02): : R35 - R50
  • [22] Metabolomics biomarkers for tuberculosis diagnostics: current status and future objectives
    du Preez, Ilse
    Luies, Laneke
    Loots, Du Toit
    BIOMARKERS IN MEDICINE, 2017, 11 (02) : 179 - 194
  • [23] Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma
    Tseng, William W.
    Seo, Hyun Jae
    Pollock, Raphael E.
    Gronchi, Alessandro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (01) : 7 - 11
  • [24] Sarcomas of the head and neck in adult, patients: current concepts and future perspectives
    Rapidis, Alexander D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1271 - 1297
  • [25] Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor
    Baldi, Giacomo G.
    Gronchi, Alessandro
    Tazzari, Marcella
    Stacchiotti, Silvia
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (05) : 491 - 503
  • [26] Examining patient perspectives on sarcoma surveillance: The Sarcoma Surveillance Survey
    Tepper, Sarah C.
    Holten, Anna K.
    Jeffe, Donna B.
    England, Patrick H.
    Hong, Zachery L.
    Perez, Maria
    Ghert, Michelle
    Hirbe, Angela C.
    Cipriano, Cara A.
    SURGICAL ONCOLOGY-OXFORD, 2022, 45
  • [27] Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future
    Ludwig, Joseph A.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (04) : 412 - 418
  • [28] Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects
    Pushpam, Deepam
    Garg, Vikas
    Ganguly, Sandip
    Biswas, Bivas
    ONCOTARGETS AND THERAPY, 2020, 13 : 5093 - 5112
  • [29] Metabolomics in Team-Sport Athletes: Current Knowledge, Challenges, and Future Perspectives
    Bongiovanni, Tindaro
    Lacome, Mathieu
    Fanos, Vassilios
    Martera, Giulia
    Cione, Erika
    Cannataro, Roberto
    PROTEOMES, 2022, 10 (03)
  • [30] Nucleoside Analogues for Chagas Disease and Leishmaniasis Therapy: Current Status and Future Perspectives
    Nwoke, Emmanuel Awucha
    Lowe, Silvester
    Aldabbagh, Fawaz
    Kalesh, Karunakaran
    Kadri, Hachemi
    MOLECULES, 2024, 29 (22):